© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
About N/A of shares are held by financial institutions. TRADEWINDS CAPITAL MANAGEMENT, LLC is the top corporate investor, holding 200 shares valued at $224.00. A 0% stake in BioLineRx Ltd. is owned by the company. GEODE CAPITAL MANAGEMENT, LLC owns 39.99K shares valued at $44.79K, which translates its holding of 0.06% of the stake in the company.
A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own BLRX shares is N/A, representing N/A of the company's common stock.
JPMORGAN CHASE & CO, in the last quarter, reduced its stake in BLRX by -100% restricting it's holding to 0 shares of worth nearly -. CITADEL ADVISORS LLC also lessened -100% of the BLRX shares from its portfolio, reducing its holding to 0 shares of worth -. SUSQUEHANNA INTERNATIONAL GROUP, LLP also shunned BLRX shares holding by -100% last quarter which brought its holding to 0 shares worth -.
As per its latest 13F filing, VALUES FIRST ADVISORS, INC. increased its stake in BLRX by 290.34% in the last quarter. The institutional holder raised its holding to 203.63 thousand shares having worth more than $228.07K. WELLS FARGO & COMPANY/MN also added 275.34% more shares of BLRX to its portfolio, raising its holding to 32.04 thousand shares of worth $35.88K. XTX TOPCO LTD also increased its BLRX shares holding by 100% which brought its holding to 31.49 thousand shares worth $35.27K.
The insider with the most stakes in BLRX is N/A , N/A at the company. Additionally, BLRX stock is highly held by N/A N/A and N/A N/A among others.
Company executives, directors, and other insiders own N/A percent of BioLineRx Ltd.'s stock. Within the last six months, there have been 0 transaction(s) in which BLRX insiders have sold stock, totaling 0 shares. Insiders that have sold shares include .
There have been 0 transaction(s) during the past 6-months in which BioLineRx Ltd. insiders have bought stock, totalling 0 shares
Around 0 BioLineRx Ltd. shares are held by insiders, which represents about N/A of BLRX stock.
BLRX N/A, N/A holds the largest portfolio of the company's shares. BLRX shares owned by N/A total nearly -.
TRADEWINDS CAPITAL MANAGEMENT, LLC is the largest institutional owner in BLRX which holds 200 shares worth $224.00 or 0% of the total BLRX shares outstanding followed by GEODE CAPITAL MANAGEMENT, LLC with ownership of 39.99 thousand shares representing 0.06% of the BLRX ownership. RATHBONES GROUP PLC is the third largest stakeholder with 39.82 thousand shares or 0.06% of the ownership worth more than $44.60K.
Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the BLRX is concerned, it is a stock which is optionable.
Number of BLRX shares short is 1.06M. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.
As of today, 142.34M shares of BLRX are outstanding.
Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, BLRX has 1.09B shares in float.
Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for BLRX is 2.39.